Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Vasomotor Symptoms: A Scoping Review
Background: Vasomotor symptoms (VMS), particularly hot flashes and night sweats, are highly prevalent during the menopausal transition and have been increasingly associated with adverse cardiometabolic profiles. Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a major mani...
| Published in: | Endocrines |
|---|---|
| Main Authors: | Anastasia Ntikoudi, Anastasia Papachristou, Afroditi Tsalkitzi, Despoina Rizikou, Eleni Evangelou, George Mastorakos, Eugenia Vlachou |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2026-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-396X/7/2/27 |
Similar Items
Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions
by: Anastasia Ntikoudi, et al.
Published: (2025-03-01)
by: Anastasia Ntikoudi, et al.
Published: (2025-03-01)
Vasomotor menopausal symptoms: is it just hot flashes? Alternative non-hormonal methods of treatment with proven effectiveness (literature review)
by: V. N. Kasyan, et al.
Published: (2021-01-01)
by: V. N. Kasyan, et al.
Published: (2021-01-01)
Psychosomatic and vasomotor symptom changes during transition to menopause
by: Areti Augoulea, et al.
Published: (2019-06-01)
by: Areti Augoulea, et al.
Published: (2019-06-01)
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
by: Khan SJ, et al.
Published: (2023-02-01)
by: Khan SJ, et al.
Published: (2023-02-01)
Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview
by: Rossella E. Nappi, et al.
Published: (2025-12-01)
by: Rossella E. Nappi, et al.
Published: (2025-12-01)
Qualitative exploration of women’s experiences of vasomotor symptoms to support the content validity of patient-reported outcomes
by: Claudia Haberland, et al.
Published: (2025-07-01)
by: Claudia Haberland, et al.
Published: (2025-07-01)
Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause
by: Neil M. Schultz, et al.
Published: (2023-11-01)
by: Neil M. Schultz, et al.
Published: (2023-11-01)
Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: Subgroup analysis from an international cross‐sectional survey
by: Angelica Lindén Hirschberg, et al.
Published: (2025-08-01)
by: Angelica Lindén Hirschberg, et al.
Published: (2025-08-01)
Characterization and Treatment Patterns of Peri/Menopausal and Postmenopausal Women with and Without Vasomotor Symptoms in a Retrospective Database Study
by: Lena Charafi, et al.
Published: (2025-01-01)
by: Lena Charafi, et al.
Published: (2025-01-01)
Oxidative stress and menopause-related hot flashes may be independent events
by: Gloria Bonaccorsi, et al.
Published: (2015-06-01)
by: Gloria Bonaccorsi, et al.
Published: (2015-06-01)
Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping Review
by: Anastasia Ntikoudi, et al.
Published: (2025-07-01)
by: Anastasia Ntikoudi, et al.
Published: (2025-07-01)
Association of lean body mass to menopausal symptoms: The Study of Women's Health Across the Nation
by: Rosanne Woods, et al.
Published: (2020-09-01)
by: Rosanne Woods, et al.
Published: (2020-09-01)
Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause
by: Andrew Trigg, et al.
Published: (2025-05-01)
by: Andrew Trigg, et al.
Published: (2025-05-01)
Investigation of the relationship between personality characteristics and vasomotor symptoms in menopausal women
by: Mahboubeh Ghorbani, et al.
Published: (2016-01-01)
by: Mahboubeh Ghorbani, et al.
Published: (2016-01-01)
A Systematic Review of Anxiety and Depressive Symptoms Among Women Experiencing Vasomotor Symptoms Across Reproductive Stages in the US
by: Gibson CJ, et al.
Published: (2025-02-01)
by: Gibson CJ, et al.
Published: (2025-02-01)
Adverse childhood experiences, age at menopause, and vasomotor symptoms among mid-life Latine adults in California
by: Suzanna Geisel-Zamora, et al.
Published: (2026-01-01)
by: Suzanna Geisel-Zamora, et al.
Published: (2026-01-01)
Women's Menopausal Experiences in the UK: A Systemic Literature Review of Qualitative Studies
by: Ailin Anto, et al.
Published: (2025-02-01)
by: Ailin Anto, et al.
Published: (2025-02-01)
Current approaches to alternative therapy in menopausal syndrome (a review)
by: A. G. Mamontova, et al.
Published: (2018-08-01)
by: A. G. Mamontova, et al.
Published: (2018-08-01)
The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms
by: F. N. Tuysuzoglu, et al.
Published: (2020-04-01)
by: F. N. Tuysuzoglu, et al.
Published: (2020-04-01)
Efficacy and safety of non-hormonal agents for vasomotor symptoms of menopause: A prospective, double-blind, placebo-controlled study
by: Viktor E. Radzinsky, et al.
Published: (2023-07-01)
by: Viktor E. Radzinsky, et al.
Published: (2023-07-01)
The Effectiveness of Cognitive Behavioral Therapy on Insomnia Severity Among Menopausal Women: A Scoping Review
by: Anastasia Ntikoudi, et al.
Published: (2024-10-01)
by: Anastasia Ntikoudi, et al.
Published: (2024-10-01)
Endometriosis and menopause—management strategies based on clinical scenarios
by: Ivika Jakson, et al.
Published: (2023-10-01)
by: Ivika Jakson, et al.
Published: (2023-10-01)
The Baseline Serum Homocysteine Levels in Peri- and Postmenopausal Women
by: Hakan Kıran, et al.
Published: (2007-04-01)
by: Hakan Kıran, et al.
Published: (2007-04-01)
Menopause part I: Vasomotor symptoms (I)
by: Peng-Hui Wang, et al.
Published: (2025-03-01)
by: Peng-Hui Wang, et al.
Published: (2025-03-01)
Effects of insomnia and non-vasomotor menopausal symptoms on coronary heart disease risk: a mendelian randomization study
by: Ie-Bin Lian, et al.
Published: (2023-02-01)
by: Ie-Bin Lian, et al.
Published: (2023-02-01)
General and Central Obesity Are Associated With Increased Severity of the VMS and Sexual Symptoms of Menopause Among Chinese Women: A Longitudinal Study
by: Ruiyi Tang, et al.
Published: (2022-04-01)
by: Ruiyi Tang, et al.
Published: (2022-04-01)
Menopause knowledge, attitudes and experiences of women in Saudi Arabia: a qualitative study
by: Ghada AlSwayied, et al.
Published: (2024-11-01)
by: Ghada AlSwayied, et al.
Published: (2024-11-01)
Biochemistry of perimenopause and menopause - in-depth study on midlife crisis among rural women in Bengal
by: Maitraye Basu, et al.
Published: (2025-07-01)
by: Maitraye Basu, et al.
Published: (2025-07-01)
Postmenopausal women's experiences of a resistance training intervention against vasomotor symptoms: a qualitative study
by: Emilia Berin, et al.
Published: (2022-07-01)
by: Emilia Berin, et al.
Published: (2022-07-01)
Effect of previous diagnoses of depression, menopause status, vasomotor symptoms, and neuroticism on depressive symptoms among climacteric women: A 30-month follow-up
by: Cheng-Hsiang Chou, et al.
Published: (2015-08-01)
by: Cheng-Hsiang Chou, et al.
Published: (2015-08-01)
Perimenopause Decreases SERCA2a Activity in the Hearts of a Mouse Model of Ovarian Failure
by: Ciara Barry, et al.
Published: (2024-06-01)
by: Ciara Barry, et al.
Published: (2024-06-01)
RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
by: Kalkan R, et al.
Published: (2020-08-01)
by: Kalkan R, et al.
Published: (2020-08-01)
The value of vitamin D for the health of perimenopausal women
by: L. A. Ozolinya, et al.
Published: (2020-10-01)
by: L. A. Ozolinya, et al.
Published: (2020-10-01)
The menopause transition: a call for a holistic approach
by: Rachel Gibbons
by: Rachel Gibbons
Needs assessment study for management of menopause in the community
by: Suchitra Mankar, et al.
Published: (2024-04-01)
by: Suchitra Mankar, et al.
Published: (2024-04-01)
CLINICAL EFFICACY OF NON-HORMONAL METHODS OF THERAPY IN PERIMENOPAUSAL WOMEN
by: T. V. Ovsyannikova, et al.
Published: (2016-06-01)
by: T. V. Ovsyannikova, et al.
Published: (2016-06-01)
An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects
by: Li Y, et al.
Published: (2025-03-01)
by: Li Y, et al.
Published: (2025-03-01)
Current Approach to Menopause
by: Sena Sayan, et al.
Published: (2017-07-01)
by: Sena Sayan, et al.
Published: (2017-07-01)
Dietary Supplementation of Myo-Inositol, Cocoa Polyphenols, and Soy Isoflavones Improves Vasomotor Symptoms and Metabolic Profile in Menopausal Women with Metabolic Syndrome: A Retrospective Clinical Study
by: Giampaolo Mainini, et al.
Published: (2024-04-01)
by: Giampaolo Mainini, et al.
Published: (2024-04-01)
Muscle and joint pains in middle-aged women are associated with insomnia and low grip strength: a cross-sectional study
by: Masakazu Terauchi, et al.
Published: (2020-01-01)
by: Masakazu Terauchi, et al.
Published: (2020-01-01)
Similar Items
-
Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions
by: Anastasia Ntikoudi, et al.
Published: (2025-03-01) -
Vasomotor menopausal symptoms: is it just hot flashes? Alternative non-hormonal methods of treatment with proven effectiveness (literature review)
by: V. N. Kasyan, et al.
Published: (2021-01-01) -
Psychosomatic and vasomotor symptom changes during transition to menopause
by: Areti Augoulea, et al.
Published: (2019-06-01) -
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
by: Khan SJ, et al.
Published: (2023-02-01) -
Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview
by: Rossella E. Nappi, et al.
Published: (2025-12-01)
